{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:56:36Z","timestamp":1773964596017,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Merosin-deficient congenital muscular dystrophy type 1A (MDC1A), also known as laminin-\u03b12 chain-deficient congenital muscular dystrophy (<jats:italic>LAMA2<\/jats:italic>-MD), is an autosomal recessive disease caused by biallelic variants in the <jats:italic>LAMA2<\/jats:italic> gene. In MDC1A, laminin- \u03b12 chain expression is absent or significantly reduced, leading to some early-onset clinical symptoms including severe hypotonia, muscle weakness, skeletal deformity, non-ambulation, and respiratory insufficiency.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Six patients from five unrelated Vietnamese families presenting with congenital muscular dystrophy were investigated. Targeted sequencing was performed in the five probands. Sanger sequencing was carried out in their families. Multiplex ligation-dependent probe amplification was performed in one family to examine an exon deletion.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Seven variants of the <jats:italic>LAMA2<\/jats:italic> (NM_000426) gene were identified and classified as pathogenic\/likely pathogenic variants using American College of Medical Genetics and Genomics criteria. Two of these variants were not reported in the literature, including c.7156-5_7157delinsT and c.8974_8975insTGAT. Sanger sequencing indicated their parents as carriers. The mothers of family 4 and family 5 were pregnant and a prenatal testing was performed. The results showed that the fetus of the family 4 only carries c.4717 + 5G&amp;gt;A in the heterozygous form, while the fetus of the family 5 carries compound heterozygous variants, including a deletion of exon 3 and c.4644C&amp;gt;A.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings not only identified the underlying genetic etiology for the patients, but also provided genetic counseling for the parents whenever they have an offspring.<\/jats:p>","DOI":"10.3389\/fgene.2023.1183663","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:35:25Z","timestamp":1686720925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Van Khanh","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc-Lan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan Ngoc Thi","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong Thi","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh Hai","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan L. A.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi Kim","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Tat","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh Van","family":"Ta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thinh Huy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huy-Hoang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.nmd.2020.03.009","article-title":"Clinical and genomic characteristics of LAMA2 related congenital muscular dystrophy in a patients\u2019 cohort from Qatar. A population specific founder variant","volume":"30","author":"Abdel Aleem","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.06.531347","article-title":"CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2 -deficiency in merosin-deficient congenital muscular dystrophy","author":"Arockiaraj","year":"2023","journal-title":"bioRxiv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2020.00001","article-title":"Laminin and integrin in LAMA2-related congenital muscular dystrophy: From disease to therapeutics","volume":"13","author":"Barraza-Flores","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41434-022-00363-0","article-title":"Changing trends in the development of AAV-based gene therapies: A meta-analysis of past and present therapies","volume":"30","author":"Burdett","year":"2023","journal-title":"Gene. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","article-title":"Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage","volume":"80","author":"Campbell","year":"1995","journal-title":"Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1387","DOI":"10.1002\/mgg3.1387","article-title":"Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy","volume":"8","author":"Cauley","year":"2020","journal-title":"Mol. Genet. Genomic. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.ctm.2015.05.002","article-title":"Laminin-\u03b12 chain-deficient congenital muscular dystrophy: Pathophysiology and development of treatment","volume":"76","author":"Durbeej","year":"2015","journal-title":"Curr. Top. Membr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12920-021-00959-2","article-title":"Identification of a novel LAMA2 c.2217G > A, p. (Trp739*) mutation in a Moroccan patient with congenital muscular dystrophy: A case report","volume":"14","author":"El Kadiri","year":"2021","journal-title":"Bmc. Med. Genomics."},{"key":"B10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.22694","article-title":"Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy(2J)\/dy(2J) mouse","volume":"71","author":"Elbaz","year":"2012","journal-title":"Ann. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.109.160754","article-title":"Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency","volume":"331","author":"Erb","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/15513815.2018.1520944","article-title":"Prenatal diagnosis of merosin-deficient muscular dystrophy","volume":"37","author":"Fadiloglu","year":"2018","journal-title":"Fetal. Pediatr. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16302","DOI":"10.1038\/s41598-018-34362-2","article-title":"Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: A gender impact study","volume":"8","author":"Fontes-Oliveira","year":"2018","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s10897-016-9993-2","article-title":"Family studies for classification of variants of uncertain classification: Current laboratory clinical practice and a new web-based educational tool","volume":"25","author":"Garrett","year":"2016","journal-title":"J. Genet. Couns."},{"key":"B15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cge.13560","article-title":"Congenital muscular dystrophies in China","volume":"96","author":"Ge","year":"2019","journal-title":"Clin. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/s0887-8994(01)00352-6","article-title":"Nonmuscular involvement in merosin-negative congenital muscular dystrophy","volume":"26","author":"Gilhuis","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.21523","article-title":"Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy","volume":"65","author":"Girgenrath","year":"2009","journal-title":"Ann. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jmg.35.3.211","article-title":"PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): Application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy","volume":"35","author":"Guicheney","year":"1998","journal-title":"J. Med. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/antiox9030244","article-title":"Antioxidants reduce muscular dystrophy in the dy2J\/dy2J mouse model of laminin \u03b12 chain-deficient muscular dystrophy","volume":"9","author":"Harandi","year":"2020","journal-title":"Antioxidants (Basel)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/cam.22618","article-title":"Laminin-211 in skeletal muscle function","volume":"7","author":"Holmberg","year":"2013","journal-title":"Cell. adh. Migr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: Case series and review","volume":"38","author":"Jones","year":"2001","journal-title":"J. Med. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nm.4367","article-title":"Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism","volume":"23","author":"Kemaladewi","year":"2017","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-019-1430-x","article-title":"A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene","volume":"572","author":"Kemaladewi","year":"2019","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.01.019","article-title":"Bortezomib partially improves laminin \u03b12 chain-deficient muscular dystrophy","volume":"184","author":"K\u00f6rner","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02185752","article-title":"Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy","volume":"97","author":"Mostacciuolo","year":"1996","journal-title":"Hum. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/TACG.S187481","article-title":"Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-\u03b12 chain-deficient congenital muscular dystrophy","volume":"12","author":"Nguyen","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/diagnostics10100741","article-title":"Whole exome sequencing as a diagnostic tool for unidentified muscular dystrophy in a Vietnamese family","volume":"10","author":"Nguyen","year":"2020","journal-title":"Diagn. (Basel)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ana.24687","article-title":"Diagnosis and etiology of congenital muscular dystrophy: We are halfway there","volume":"80","author":"O\u2019Grady","year":"2016","journal-title":"Ann. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1399-0004.2008.01068.x","article-title":"LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients","volume":"74","author":"Oliveira","year":"2008","journal-title":"Clin. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/JND-140031","article-title":"Reviewing large LAMA2 deletions and duplications in congenital muscular dystrophy patients","volume":"1","author":"Oliveira","year":"2014","journal-title":"J. Neuromuscul. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-\u03b12 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum. Mutat."},{"key":"B34","article-title":"LAMA2 muscular dystrophy","volume-title":"GeneReviews\u00ae","author":"Oliveira","year":"2020"},{"key":"B35","doi-asserted-by":"publisher","first-page":"dmm049916","DOI":"10.1242\/dmm.049916","article-title":"Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy","volume":"16","author":"Oliveira-Santos","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"B36","volume-title":"Congenital muscular dystrophy","author":"Pasrija","year":"2022"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1212\/wnl.51.1.101","article-title":"Laminin alpha2 muscular dystrophy: Genotype\/phenotype studies of 22 patients","volume":"51","author":"Pegoraro","year":"1998","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/adc.80.6.542","article-title":"Feeding problems in merosin deficient congenital muscular dystrophy","volume":"80","author":"Philpot","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"B39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnmol.2020.00060","article-title":"LAMA2 neuropathies: Human findings and pathomechanisms from mouse models","volume":"13","author":"Previtali","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13073-021-00835-9","article-title":"CADD-splice\u2014Improving genome-wide variant effect prediction using deep learning-derived splice scores","volume":"13","author":"Rentzsch","year":"2021","journal-title":"Genome. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jbmr.4454","article-title":"Molecular diagnoses of X-linked and other genetic hypophosphatemias: Results from a sponsored genetic testing program","volume":"37","author":"Rush","year":"2022","journal-title":"J. Bone. Min. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.nmd.2019.04.001","article-title":"Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI","volume":"29","author":"Saredi","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-related dystrophies: Clinical phenotypes, disease biomarkers, and clinical trial readiness","volume":"13","author":"Sarkozy","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.46531\/sinapse\/CC\/220030\/2022","article-title":"Congenital muscular dystrophy type 1A: The role of multidisciplinary rehabilitation","volume":"22","author":"Sousa","year":"2022","journal-title":"Sinapse"},{"key":"B46","doi-asserted-by":"publisher","first-page":"W446","DOI":"10.1093\/nar\/gkab266","article-title":"Mutation Taster2021","volume":"49","author":"Steinhaus","year":"2021","journal-title":"Nucleic. Acids Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13023-021-01950-x","article-title":"Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort","volume":"16","author":"Tan","year":"2021","journal-title":"Orphanet. J. Rare Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/humu.10157","article-title":"Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency","volume":"21","author":"Tezak","year":"2003","journal-title":"Hum. Mutat."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41436-020-0840-3","article-title":"Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness","volume":"22","author":"T\u00f6pf","year":"2020","journal-title":"Genet. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/br.2019.1260","article-title":"A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report","volume":"12","author":"Tran","year":"2020","journal-title":"Biomed. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.nmd.2005.04.009","article-title":"Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: A collective experience of five international centers","volume":"15","author":"Vainzof","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nmd.2003.09.003","article-title":"117th ENMC workshop: Ventilatory support in congenital neuromuscular disorders -- congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 april 2003, naarden, The Netherlands","volume":"14","author":"Wallgren-Pettersson","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cge.12366","article-title":"Genotype\/phenotype analysis in Chinese laminin-\u03b12 deficient congenital muscular dystrophy patients","volume":"87","author":"Xiong","year":"2015","journal-title":"Clin. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.nmd.2021.07.009","article-title":"Congenital muscular dystrophies: What is new?","volume":"31","author":"Zambon","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/acn3.51172","article-title":"LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort","volume":"7","author":"Zambon","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1183663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:35:30Z","timestamp":1686720930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1183663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":55,"alternative-id":["10.3389\/fgene.2023.1183663"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1183663","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"article-number":"1183663"}}